A 58-year-old man with small-cell lung cancer presents with confusion and lethargy. Serum sodium is 118 mEq/L. Physical examination shows euvolemia with no edema. Urine osmolality is 650 mOsm/kg and urine sodium is 85 mEq/L. What is the most appropriate immediate management?

## Clinical Diagnosis: SIADH with Severe Symptomatic Hyponatremia ### Key Diagnostic Features **Key Point:** The combination of euvolemia + hyponatremia (Na 118 mEq/L) + inappropriately concentrated urine (osmolality 650 mOsm/kg) + elevated urine sodium (85 mEq/L) in a patient with small-cell lung cancer is pathognomonic for SIADH. **Clinical Pearl:** Small-cell lung cancer is the most common malignancy causing SIADH, accounting for ~15% of all SIADH cases due to ectopic ADH secretion. ### Why Hypertonic (3%) Saline is the Correct Immediate Management The patient presents with **Na 118 mEq/L** accompanied by **neurological symptoms (confusion and lethargy)**. Per Harrison's Principles of Internal Medicine (21e, Ch. 297) and current guidelines (European Clinical Practice Guidelines 2014): 1. **Symptomatic Hyponatremia Requires Urgent Treatment:** Confusion and lethargy represent moderate-to-severe neurological symptoms of hyponatremia. These symptoms indicate cerebral edema and mandate prompt correction with hypertonic saline regardless of chronicity. 2. **Na 118 mEq/L with Neurological Symptoms = Hypertonic Saline Indication:** The threshold for hypertonic saline is not solely Na < 115 — it is any symptomatic hyponatremia with neurological manifestations. Confusion and lethargy clearly qualify. 3. **Fluid Restriction is Insufficient for Acute Neurological Symptoms:** Fluid restriction raises serum sodium by only 2–3 mEq/L per day — far too slow to reverse active cerebral edema causing confusion and lethargy. It is appropriate only for **asymptomatic** chronic SIADH. 4. **Duration Ambiguity Resolved by Symptoms:** When the duration is unspecified and the patient has neurological symptoms, the clinical imperative is to treat the symptoms urgently. The presence of confusion/lethargy overrides the chronic-default assumption. ### Management Protocol - **Hypertonic 3% saline:** Bolus 100–150 mL over 20 minutes, may repeat 1–2 times until symptoms improve - **Target:** Raise Na by 4–6 mEq/L in the first 1–2 hours to relieve cerebral edema - **Correction limit:** Do NOT exceed 10–12 mEq/L in 24 hours (or 18 mEq/L in 48 hours) to prevent osmotic demyelination syndrome (central pontine myelinolysis) - **Reassess:** Serum sodium every 2–4 hours; transition to fluid restriction once symptoms resolve ### Why Other Options Are Wrong - **B) Demeclocycline:** A chronic management option for SIADH; onset takes days — not appropriate for acute symptomatic hyponatremia. - **C) Fluid restriction:** Appropriate for **asymptomatic** chronic SIADH only; raises Na too slowly (2–3 mEq/L/day) to address active neurological symptoms. - **D) Normal saline:** Contraindicated in SIADH — isotonic saline may paradoxically worsen hyponatremia because the kidney excretes the sodium but retains the free water when urine osmolality exceeds plasma osmolality. **High-Yield:** In any patient with hyponatremia AND neurological symptoms (confusion, lethargy, seizures, coma), hypertonic saline is the immediate treatment of choice. Fluid restriction is reserved for asymptomatic or mildly symptomatic chronic SIADH. [cite: Harrison 21e Ch 297; European Clinical Practice Guidelines on Hyponatraemia 2014]